Early Stage Venture Scorpion Therapeutics Raises Series A of $108000000

October 26, 2020

About Scorpion Therapeutics

Scorpion Therapeutics is a next-generation precision oncology company.

Website: Learn more on Scorpion Therapeutics’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – Scorpion Therapeutics

Amount Raised108000000 USD
Announced Date2020-10-26
Equity Only FundingYes
Organization LocationBoston, Massachusetts, United States, North America
Funding StatusEarly Stage Venture
Number of Funding Rounds1
Lead InvestorsAtlas Venture, Omega Funds, Vida Ventures
Number of Investors5
Number of Partner Investors3